Declining Recent Interest in Histogen and Replicel
Several years ago, the two companies that hair loss sufferers cared about the most were Histogen and Replicel. Over time, news releases from Histogen slowed down and their published results were not especially impressive to the casual observer. While Replicel has remained highly active when it comes to news releases (probably more so than any other company ever involved in the hair loss cure world) and especially responsive on social media platforms, several delays in the company’s clinical trials have turned off many people. Moreover, just as with Histogen, it is not yet entirely clear as to how great Replicel’s results will be. It is assumed that once they use many injections, results will be significantly superior to what they have already shown in initial trials involving a limited number of injections. When it comes to Replicel, making things even less clear is the fact that Replicel’s much larger Japanese partner Shiseido is supplementing Replicel’s technology with its own technology. Below is an instructive chart showing Google Trends search results for keywords “Histogen” and “Replicel” since the start of 2008. Histogen is in red and Replicel is in blue, with the former causing the most excitement in 2010 and the latter in 2012.
Histogen Awakens from its Slumber
After not hearing much about Histogen in the past year, it was a pleasant surprise for me to learn that Histogen and its CEO Gail Naughton will be presenting at the upcoming 9th World Congress for Hair Research in Miami, Florida in November, 2015. I will be covering the details of this Congress in more detail in the coming weeks. See the news page on Histogen’s website that describes Dr. Naughton’s upcoming presentation.
Moreover, several months ago Histogen successfully garnered around $10 million in new financing that I mentioned in my brief items of interest post on this blog in July 2015. Also of interest, Histogen published a new promo video on youtube about 3 months ago that I only saw recently:
Replicel Keeps Presenting and Tweeting Regularly
It seems like Replicel has continued to come out with new presentations virtually every 2 months during the past several years. The latest from this month can be read here as well as seen in the video below. That video is from a presentation by Lee Buckler at this month’s Alliance for Regenerative Medicine (ARM)’s annual “Stem Cell Meeting on the Mesa” conference in San Diego, California. It is worth watching most of the video’s on ARM’s youtube channel. In the past, both Histogen and Replicel have presented at this annual conference, but this year it was only the latter.